Bristol Myers Squibb extends its longstanding commitment to cancer research through the C2C4C ride in Latin America

Bristol Myers Squibb has kicked off Continent 2 Continent 4 Cancer (C2C4C), a 12-day cycling event in Latin America for cancer research. It also marks a decade of C2C4C and riding for cancer patients, as well as celebrates the company’s commitment to do more for those impacted by cancer worldwide. Fifty-five employees are cycling in Latin America this year, their motivation to participate and advance cancer research is personal. Some are riding in honour of those who have lost their lives to cancer or are currently battling the disease. Others have experienced a cancer diagnosis themselves.  

From 2-13 of December, Bristol Myers Squibb employees will ride between Pucón, Chile and Puerto Varas, Chile for nearly 1,500 kilometres total. Their goal is to raise funds for Latin American cancer organisations, who are UICC members. Bristol Myers Squibb will donate up to $50,000 USD to UICC to support rider fundraising efforts. Since 2022, more than $125,000 USD has been donated to charitable organisations in Latin America via the C2C4C ride.

In Latin America, the ride will be more diverse and inclusive than ever, with employees from seven participating countries: Argentina, Brazil, Chile, Colombia, Mexico, Peru and the United States. Employees from Brazil will be participating in the ride for the first time. Together, their miles will make more memories for cancer patients and their loved ones.

To support riders as they raise money for local cancer organisations in Latin America, please visit the dedicated page or follow the ride on LinkedIn,  Facebook and Instagram using #C2C4C23.   

About C2C4C 

For 10 years, the global Bristol Myers Squibb workforce has come together to demonstrate its long-standing commitment to cancer research through the Country 2 Country 4 Cancer (Europe), Coast 2 Coast 4 Cancer (United States), and Continent 2 Continent 4 Cancer (Japan and Latin America) bike rides – collectively known as C2C4C. The tradition began in 2014 when a group of oncology employees in the United States were compelled to do more for those impacted by cancer. Those efforts expanded to Europe in 2016, Japan in 2021 and Latin America in 2022. In the U.S., across Europe, in Japan and in Latin America, the ride includes hundreds of employees representing more than 30 nations, who volunteer their time to train, fundraise and participate in these epic bike rides where their miles make more memories for cancer patients and their loved ones. Since its inception, more than $14 million USD has been donated to advance cancer research worldwide.